Get the app
public
ios_share
OncoPharm
chevron_right
Mirvetuximab Soravtansine
Nov 17, 2022
19:29
forum
Ask episode
play_arrow
Play
view_agenda
Chapters
auto_awesome
Transcript
info_circle
Episode notes
A new antibody-drug conjugate is approved for ovarian cancer.